SCHEMBL3402525

SCHEMBL3402525

Cc1cccc(C)c1Nc1c(-c2ccccc2-c2cccc(OC(=O)O)c2)nc2ccccn12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 8/20 0.51
MAPT P10636 7/20 0.51
TP53 P04637 4/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
MAPK1 P28482 2/20 0.50
KMT2A Q03164 2/20 0.50
HTT P42858 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
TUBB4A P04350 2/20 0.46
TUBB P07437 2/20 0.46
TUBA3C P0DPH7 2/20 0.46
TUBA1B P68363 2/20 0.46
TUBA4A P68366 2/20 0.46
TUBB4B P68371 2/20 0.46
TUBB3 Q13509 2/20 0.46
TUBB2A Q13885 2/20 0.46
TUBB8 Q3ZCM7 2/20 0.46
TUBA3E Q6PEY2 2/20 0.46
TUBA1A Q71U36 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1086917 0.85 GAA (0.55) GAAMAPTTP53SMN1; SMN2MAPK1
SCHEMBL1097764 0.83 GAA (0.54) GAAMAPTTP53SMN1; SMN2MAPK1
SCHEMBL2291064 0.77 GAA (0.54) GAAMAPTTP53SMN1; SMN2MAPK1
SCHEMBL1097370 0.77 GAA (0.59) GAAMAPTTP53SMN1; SMN2MAPK1
SCHEMBL2611912 0.74 GAA (0.61) GAAMAPTTP53SMN1; SMN2MAPK1
SCHEMBL2611940 0.73 GAA (0.60) GAAMAPTTP53SMN1; SMN2MAPK1
SCHEMBL2292074 0.73 GAA (0.52) GAAMAPTTP53SMN1; SMN2MAPK1
SCHEMBL2288504 0.73 GAA (0.54) GAAMAPTTP53SMN1; SMN2MAPK1
SCHEMBL2289252 0.73 GAA (0.53) GAAMAPTTP53SMN1; SMN2MAPK1
SCHEMBL16266137 0.73 GAA (0.53) GAAMAPTTP53SMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097411-B1 3 -AMINO-IMIDAZO [1,2 -A]PYRIDINE DERIVATIVES HAVING AN SGLT1 AND SGLT2 INHIBITING ACTION, FOR TREATING TYPE 1 AND TYPE 2 DIABETES MERCK PATENT GMBH (DE) 2010-11-17 EP claimed
EP-2097411-B1 3 -AMINO-IMIDAZO [1,2 -A]PYRIDINE DERIVATIVES HAVING AN SGLT1 AND SGLT2 INHIBITING ACTION, FOR TREATING TYPE 1 AND TYPE 2 DIABETES MERCK PATENT GMBH (DE) 2010-11-17 EP disclosed